Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays.
García JF, Camacho FI, Morente M, Fraga M, Montalbán C, Alvaro T, Bellas C, Castaño A, Díez A, Flores T, Martin C, Martinez MA, Mazorra F, Menárguez J, Mestre MJ, Mollejo M, Sáez AI, Sánchez L, Piris MA; Spanish Hodgkin Lymphoma Study Group. García JF, et al. Among authors: menarguez j. Blood. 2003 Jan 15;101(2):681-9. doi: 10.1182/blood-2002-04-1128. Epub 2002 Sep 12. Blood. 2003. PMID: 12393683 Free article.
Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis.
Ruiz-Ballesteros E, Mollejo M, Rodriguez A, Camacho FI, Algara P, Martinez N, Pollán M, Sanchez-Aguilera A, Menarguez J, Campo E, Martinez P, Mateo M, Piris MA. Ruiz-Ballesteros E, et al. Among authors: menarguez j. Blood. 2005 Sep 1;106(5):1831-8. doi: 10.1182/blood-2004-10-3898. Epub 2005 May 24. Blood. 2005. PMID: 15914563 Free article.
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma.
Sánchez-Aguilera A, Montalbán C, de la Cueva P, Sánchez-Verde L, Morente MM, García-Cosío M, García-Laraña J, Bellas C, Provencio M, Romagosa V, de Sevilla AF, Menárguez J, Sabín P, Mestre MJ, Méndez M, Fresno MF, Nicolás C, Piris MA, García JF; Spanish Hodgkin Lymphoma Study Group. Sánchez-Aguilera A, et al. Among authors: menarguez j. Blood. 2006 Jul 15;108(2):662-8. doi: 10.1182/blood-2005-12-5125. Epub 2006 Mar 21. Blood. 2006. PMID: 16551964 Free article.
A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma.
Sánchez-Espiridión B, Montalbán C, López A, Menárguez J, Sabín P, Ruiz-Marcellán C, Lopez A, Ramos R, Rodríguez J, Cánovas A, Camarero C, Canales M, Alves J, Arranz R, Acevedo A, Salar A, Serrano S, Bas A, Moraleda JM, Sánchez-Godoy P, Burgos F, Rayón C, Fresno MF, Laraña JG, García-Cosío M, Santonja C, López JL, Llanos M, Mollejo M, González-Carrero J, Marín A, Forteza J, García-Sanz R, Tomás JF, Morente MM, Piris MA, García JF; Spanish Hodgkin Lymphoma Study Group. Sánchez-Espiridión B, et al. Among authors: menarguez j. Blood. 2010 Aug 26;116(8):e12-7. doi: 10.1182/blood-2010-02-270009. Epub 2010 May 17. Blood. 2010. PMID: 20479282 Free article. Clinical Trial.
Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.
Camacho FI, Algara P, Rodríguez A, Ruíz-Ballesteros E, Mollejo M, Martínez N, Martínez-Climent JA, González M, Mateo M, Caleo A, Sánchez-Beato M, Menárguez J, García-Conde J, Solé F, Campo E, Piris MA. Camacho FI, et al. Among authors: menarguez j. Blood. 2003 May 15;101(10):4042-6. doi: 10.1182/blood-2002-11-3456. Epub 2003 Jan 2. Blood. 2003. PMID: 12511405 Free article.
MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma.
Sánchez-Espiridión B, Martín-Moreno AM, Montalbán C, Figueroa V, Vega F, Younes A, Medeiros LJ, Alvés FJ, Canales M, Estévez M, Menarguez J, Sabín P, Ruiz-Marcellán MC, Lopez A, Sánchez-Godoy P, Burgos F, Santonja C, López JL, Piris MA, Garcia JF. Sánchez-Espiridión B, et al. Among authors: menarguez j. Br J Haematol. 2013 Aug;162(3):336-47. doi: 10.1111/bjh.12390. Epub 2013 Jun 1. Br J Haematol. 2013. PMID: 23725219 Free PMC article.
Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement.
Rodríguez A, Martínez N, Camacho FI, Ruíz-Ballesteros E, Algara P, García JF, Menárguez J, Alvaro T, Fresno MF, Solano F, Mollejo M, Martin C, Piris MA. Rodríguez A, et al. Among authors: menarguez j. Clin Cancer Res. 2004 Oct 15;10(20):6796-806. doi: 10.1158/1078-0432.CCR-04-0753. Clin Cancer Res. 2004. PMID: 15501956
Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.
Morente MM, Piris MA, Abraira V, Acevedo A, Aguilera B, Bellas C, Fraga M, Garcia-Del-Moral R, Gomez-Marcos F, Menarguez J, Oliva H, Sanchez-Beato M, Montalban C. Morente MM, et al. Among authors: menarguez j. Blood. 1997 Sep 15;90(6):2429-36. Blood. 1997. PMID: 9310494 Free article.
98 results